Koch, E.A.T.; Liguori, R.; Castro, A.A.; Schliep, S.; Petzold, A.; Wessely, A.; Fröhlich, W.; Ferrazzi, F.; Vera, J.; Eckstein, M.;
et al. Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8. Int. J. Mol. Sci. 2025, 26, 9964.
https://doi.org/10.3390/ijms26209964
AMA Style
Koch EAT, Liguori R, Castro AA, Schliep S, Petzold A, Wessely A, Fröhlich W, Ferrazzi F, Vera J, Eckstein M,
et al. Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8. International Journal of Molecular Sciences. 2025; 26(20):9964.
https://doi.org/10.3390/ijms26209964
Chicago/Turabian Style
Koch, Elias A. T., Renato Liguori, Alejandro Afonso Castro, Stefan Schliep, Anne Petzold, Anja Wessely, Waltraud Fröhlich, Fulvia Ferrazzi, Julio Vera, Markus Eckstein,
and et al. 2025. "Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8" International Journal of Molecular Sciences 26, no. 20: 9964.
https://doi.org/10.3390/ijms26209964
APA Style
Koch, E. A. T., Liguori, R., Castro, A. A., Schliep, S., Petzold, A., Wessely, A., Fröhlich, W., Ferrazzi, F., Vera, J., Eckstein, M., Berking, C., & Heppt, M. V.
(2025). Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8. International Journal of Molecular Sciences, 26(20), 9964.
https://doi.org/10.3390/ijms26209964